Inhibition of Cyclooxygenase-2 Indirectly Potentiates Antitumor Effects of Photodynamic Therapy in Mice

Clinical Cancer Research

Volumn 9, Issue 14, 2003, Pages 5417-5422

  Makowski, Marcin ^a   Grzela, Tomasz ^a,b   Niderla, Justyna ^a   Łazarczyk, Maciej ^a   Mróz, Paweł ^a   Kopeć, Maciej ^a   Legat, Magdalena ^a   Strusińska, Katarzyna ^a   Koziak, Katarzyna ^b   Nowis, Dominika ^a   Mrówka, Piotr ^a   Wa̧sik, Maria ^b   Jakóbisiak, Marek ^a   Goła̧b, Jakub ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450; HEME OXYGENASE 1; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PHOTOFRIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; ROFECOXIB;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; DRUG POTENTIATION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC CODE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIHEMATOPORPHYRIN ETHER; GENE EXPRESSION PROFILING; HUMANS; ISOENZYMES; LIGHT; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOTOCHEMOTHERAPY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 10744222642     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst., 90: 889-905, 1998.
2. McBride, G. Studies expand potential uses of photodynamic therapy. J. Natl. Cancer Inst., 94: 1740-1742, 2002.
3. Sharman, W. M., Allen, C. M., and van Lier, J. E. Role of activated oxygen species in photodynamic therapy. Methods Enzymol., 319: 376-400, 2000.
4. Fingar, V. H., Wieman, T. J., Wiehle, S. A., and Cerrito, P. B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res., 52: 4914-4921, 1992.
5. van Duijnhoven, F. H., Aalbers, R. I., Rovers, J. P., Terpstra, O. T., and Kuppen, P. J. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology, 207: 105-113, 2003.
6. Henderson, B. W., and Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
7. Dolmans, D. E., Fukumura, D., and Jain, R. K. Photodynamic therapy for cancer. Nat. Rev. Cancer, 3: 380-387, 2003.
8. Nelson, J. S., McCullough, J. L., and Berns, M. W. Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice. J. Natl. Cancer Inst., 80: 56-60, 1988.
9. White, L., Gomer, C. J., Doiron, D. R., and Szirth, B. C. Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model. Br. J. Cancer, 57: 455-458, 1988.
10. Moor, A. C. Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. B, 57: 1-13. 2000.
11. Goła̧b, J., Nowis, D., Skrzycki, M., Czeczot, H., Barańczyk-Kuźma, A., Wilczyński, G. M., Makowski, M., Mróz, P., Kozar, K., Kamiñski, R., Jalili, A., Kopeć, M., Grzela, T., and Jakóbisiak, M. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J. Biol. Chem., 278: 407-414, 2003.
12. Goła̧b, J., Stokłosa, T., Zagozdzon, R., Kaca, A., Giermasz, A., Pojda, Z., Machaj, E., Da̧browska, A., Feleszko, W., Lasek, W., Iwan-Osiecka, A., and Jakóbisiak, M. G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice. Ann. Oncol., 9: 63-69, 1998.
13. Ferrario, A., von Tiehl, K., Wong, S., Luna, M., and Gomer, C. J. Cycloxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res., 62: 3956-3961, 2002.
14. Muller, S., Walt, H., Dobler-Girdziunaite, D., Fiedler, D., and Haller, U. Enhanced photodynamic effects using fractionated laser light. J. Photochem. Photobiol. B, 42: 67-70, 1998.
15. Jirsa, M., Jr., Pouckova, P., Dolezal, J., Pospisil, J., and Jirsa, M. Hyperbaric oxygen and photodynamic therapy in tumour-bearing nude mice. Eur. J. Cancer, 27: 109, 1991.
16. Goła̧b, J., Olszewska, D., Mróz, P., Kozar, K., Kamiński, R., Jalili, A., and Jakóbisiak, M. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin. Cancer Res., 8: 1265-1270, 2002.
17. Krosl, G., Korbelik, M., Krosl, J., and Dougherty, G. J. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res., 56: 3281-3286, 1996.
18. Goła̧b, J., Wilczyński, G., Zagozdzon, R., Stokłosa, T., Da̧browska, A., Rybczyńska, J., Wa̧sik, M., Machaj, E., Ołdak, T., Kozar, K., Kamiński, R., Giermasz, A., Czajka, A., Lasek. W., Feleszko, W., and Jakóbisiak, M. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br. J. Cancer, 82: 1485-1491, 2000.
19. Verwanger, T., Sanovic, R., Aberger, F., Frischauf, A. M., and Krammer, B. Gene expression pattern following photodynamic treatment of the carcinoma cell line A-431 analysed by cDNA arrays. Int. J. Oncol., 21: 1353-1359, 2002.
20. Wang, H. P., Hanlon, J. G., Rainbow, A. J., Espiritu, M., and Singh, G. Up-regulation of Hsp27 plays a role in the resistance of human colon carcinoma HT29 cells to photooxidative stress. Photochem. Photobiol., 76: 98-104, 2002.
21. Hida, T., Kozaki, K., Ito, H., Miyaishi, O., Tatematsu, Y., Suzuki, T., Matsuo, K., Sugiura, T., Ogawa, M., and Takahashi, T. Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Clin. Cancer Res., 8: 2443-2447, 2002.
22. Milas, L., Kishi, K., Hunter, N., Mason, K., Masferrer, J. L., and Tofilon, P. J. Enhancement of tumor response to γ-radiation by an inhibitor of cyclooxygenase-2 enzyme. J. Natl. Cancer Inst., 91: 1501-1504, 1999.
23. Pyo, H., Choy, H., Amorino, G. P., Kim, J. S., Cao, Q., Hercules, S. K., and DuBois, R. N. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin. Cancer Res., 7: 2998-3005, 2001.
24. Hida, T., Kozaki. K., Muramatsu, H., Masuda, A., Shimizu, S., Mitsudomi, T., Sugiura, T., Ogawa, M., and Takahashi, T. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin. Cancer Res., 6: 2006-2011, 2000.
25. Zhu, J., Song, X., Lin, H. P., Young, D. C., Yan, S., Marquez, V. E., and Chen, C. S. Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. J. Natl. Cancer Inst., 94: 1745-1757, 2002.
26. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
27. Seed, M. P., Freemantle, C. N., Alam, C. A., Colville-Nash, P. R., Brown, J. R., Papworth, J. L., Somerville, K. W., and Willoughby, D. A. Apoptosis induction and inhibition of colon-26 tumour growth and angiogenesis: findings on COX-1 and COX-2 inhibitors in vitro & in vivo and topical diclofenac in hyaluronan. Adv. Exp. Med. Biol., 433: 339-342, 1997.
28. Majima, M., Hayashi, I., Muramatsu, M., Katada, J., Yamashina, S., and Katori, M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol., 130: 641-649, 2000.
29. Henderson, B. W., Waldow, S. M., Mang, T. S., Potter, W. R., Malone, P. B., and Dougherty, T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res., 45: 572-576, 1985.
30. Fingar, V. H., and Henderson, B. W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem. Photobiol., 46: 837-841, 1987.
31. Dolmans, D. E., Kadambi, A., Hill, J. S., Flores, K. R., Gerber, J. N., Walker, J. P., Rinkes, I. H., Jain, R. K., and Fukumura, D. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res., 62: 4289-4294, 2002.
32. Ferrario, A., von Tiehl, K. F., Rucker, N., Schwarz, M. A., Gill, P. S., and Gomer, C. J. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res., 60: 4066-4069, 2000.
33. FitzGerald, G. A., and Patrono, C. Drug Therapy: The Coxibs, Selective Inhibitors of Cyclooxygenase-2. N. Engl. J. Med., 345: 433-442, 2001.
34. Sabino, M. A., Ghilardi, J. R., Jongen, J. L., Keyser, C. P., Luger, N. M., Mach, D. B., Peters, C. M., Rogers, S. D., Schwei, M. J., de Felipe, C., and Mantyh, P. W. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res., 62: 7343-7349, 2002.